Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Partial Seizures”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Post-approval studies (Phase 4)Ended earlyNCT01546688
What this trial is testing

Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Limited 41
Large-scale testing (Phase 3)Study completedNCT01142193
What this trial is testing

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Who this might be right for
Epilepsy
Upsher-Smith Laboratories 249
Not applicableEnded earlyNCT04839601
What this trial is testing

RNS System RESPONSE Study

Who this might be right for
EpilepsyPartial SeizureNeurostimulator; Complications+2 more
NeuroPace 9
Large-scale testing (Phase 3)Study completedNCT00615615
What this trial is testing

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 216
Large-scale testing (Phase 3)Ended earlyNCT00372528
What this trial is testing

An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures

Who this might be right for
Epilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 21
Early research (Phase 1)Study completedNCT00233012
What this trial is testing

The Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Who this might be right for
Seizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 16
Testing effectiveness (Phase 2)Ended earlyNCT01545518
What this trial is testing

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Who this might be right for
Epilepsy, CryptogenicEpilepsy, PartialSeizure Disorder+2 more
Emory University 20
Post-approval studies (Phase 4)Ended earlyNCT05684978
What this trial is testing

Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus

Who this might be right for
Refractory Status Epilepticus
Wayne State University 1
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Testing effectiveness (Phase 2)Ended earlyNCT04153175
What this trial is testing

Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

Who this might be right for
Refractory Epilepsy
Cerebral Therapeutics LLC 30
Large-scale testing (Phase 3)Study completedNCT00988156
What this trial is testing

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Who this might be right for
Partial Epilepsy in Children and Adolescents
Bial - Portela C S.A. 304
Large-scale testing (Phase 3)Study completedNCT00368069
What this trial is testing

Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Who this might be right for
Epilepsy
UCB Pharma 158
Testing effectiveness (Phase 2)Study completedNCT00871377
What this trial is testing

Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures

Who this might be right for
Epilepsy
National Center for Complementary and Integrative Health (NCCIH) 24
Testing effectiveness (Phase 2)Study completedNCT00236860
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 56
Testing effectiveness (Phase 2)WithdrawnNCT00567424
What this trial is testing

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Who this might be right for
Epilepsy
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00699972
What this trial is testing

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 390
Testing effectiveness (Phase 2)Study completedNCT00152503
What this trial is testing

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Who this might be right for
Epilepsy, Partial
UCB Pharma SA 59
Large-scale testing (Phase 3)Study completedNCT00292461
What this trial is testing

Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

Who this might be right for
Epilepsy
Eisai Inc. 64
Large-scale testing (Phase 3)Study completedNCT00319501
What this trial is testing

Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.

Who this might be right for
SeizuresEpilepsies, PartialEpilepsy, Complex Partial+2 more
Pfizer 234
Early research (Phase 1)UnknownNCT03024827
What this trial is testing

Cannabidiol in Children With Refractory Epileptic Encephalopathy

Who this might be right for
Epileptic Encephalopathy
University of Saskatchewan 20
Load More Results